FDA 483 - Lucid Diagnostics, Inc. - March 21, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Lucid Diagnostics, Inc. in Foxborough, MA, a medical device manufacturer, identified a significant issue with the firm's complaint handling procedures. Specifically, the company failed to adequately establish and follow procedures for receiving, reviewing, and evaluating complaints, leading to an insufficient investigation of an alleged EsoCheck balloon deflation problem. This indicates a deficiency in their quality system regarding post-market surveillance and complaint management.
ID · 92e9157f-d3c2-4701-bfbb-971a537fe698